Study of the sequence of events involved in nevirapine-induced skin rash in Brown Norway rats

Chemical Research in Toxicology

Volumn 19, Issue 9, 2006, Pages 1205-1214

  Popovic, Marija ^a,e   Caswell, Jeff L ^c   Mannargudi, Baskar ^a   Shenton, Jacintha M ^d   Uetrecht, Jack P ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

^d BRISTOL MYERS SQUIBB COMPANY   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEVIRAPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG STRUCTURE; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; LIVER TOXICITY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; NONHUMAN; RASH; RAT; RAT STRAIN; SKIN DEFECT; T LYMPHOCYTE;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXANTHEMA; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; MAJOR HISTOCOMPATIBILITY COMPLEX; NEVIRAPINE; RATS; REVERSE TRANSCRIPTASE INHIBITORS;

ANIMALIA; LETHRINUS RUBRIOPERCULATUS; RATTUS NORVEGICUS;

EID: 33748995692     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx0601152     Document Type: Article

References (12)

1. Pollard, R. B., Robinson, P., and Dransfield, K. (1998) Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection. Clin. Ther. 20, 1071-1092.
2. Montaner, J. S., Cahn, P., Zala, C., Casssetti, L. I., Losso, M., Hall, D. B., Wruck, J., McDonough, M., Gigliotti, M., Robinson, P. A., and 1100.1286 Study Team. (2003) Randomized, controlled study of the effects of a short course of prednisone on the incidence of rash associated with nevirapine in patients infected with HIV-1. J. Acquired Immune Defic. Syndr. 33, 41-46.
3. Bersoff-Matcha, S. J., Miller, W. C., Aberg, J. A., Van Der Horst, C., Hamrick, H. J., Jr., Powderly, W. G., and Mundy, L. M. (2001) Sex differences in nevirapine rash. Clin. Infect. Dis. 32, 124-129.
4. Johnson, S., and Baraboutis, J. G. (2000) Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers. JAMA 284, 2722-2723.
5. Shenton, J. M., Teranishi, M., Abu-Asab, M. S., Yager, J. A., and Uetrecht, J. P. (2003) Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat. Chem. Res. Toxicol. 16, 1078-1089.
6. Shenton, J. M., Popovic, M., Chen, J., Masson, M. J., and Uetrecht, J. P. (2005) Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female Brown Norway rat. Chem. Res. Toxicol. 18, 1799-1813.
7. Ackermann, L., and Harvima, I. T. (1998) Mast cells of psoriatic and atopic dermatitis skin are positive for TNF-alpha and their degranulation is associated with expression of ICAM-1 in the epidermis. Arch. Dermatol. Res. 290, 353-359.
8. Harding, C. V., and Unanue, E. R. (1990) Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 346, 574-576.
9. Janeway, C. A., Jr., Bottomly, K., Horowitz, J., Kaye, J., Jones, B., and Tite, J. (1985) Modes of cell:cell communication in the immune system. J. Immunol. 135, 739s-742s.
10. Steiniger, B., Van der Meide, P. H., Falk, P., and Klempnauer, J. (1988) Induction of class II MHC antigen expression in rat organs after systemic application of recombinant gamma interferon. Adv. Exp. Med. Biol. 237, 795-799.
11. Hao, L. M., Wang, Y., Gill, R. G., La Rosa, F. G., Talmage, D. W., and Lafferty, K. J. (1989) Role of gamma-interferon in islet allograft rejection: class I MHC antigen induction. Transplant Proc. 21, 2697-2699.
12. Zanni, M. P., Mauri-Hellweg, D., Brander, C., Wendland, T., Schnyder, B., Frei, E., Von Greyerz, S., Bircher, A., and Pichler, W. J. (1997) Characterization of lidocaine-specific T cells. J. Immunol. 158, 1139-1148.